Citalopram, a selective serotonin reuptake inhibitor, improves symptoms of Friedreich's ataxia

Pharmacopsychiatry

Volumn 32, Issue 3, 1999, Pages 113-114

  Rohr, A ^a   Eichler, K ^b   Hafezi Moghadam, N ^b  

^a NONE   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; ACETYLCHOLINE; AMANTADINE; BACLOFEN; BENSERAZIDE; BUSPIRONE; CITALOPRAM; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TIZANIDINE;

ABETALIPOPROTEINEMIA; ADULT; ALPHA TOCOPHEROL DEFICIENCY; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CASE REPORT; CHROMOSOME MAP; CLINICAL FEATURE; DEGENERATIVE DISEASE; DEPRESSION; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFICACY; ELECTROCARDIOGRAM; FEMALE; FRIEDREICH ATAXIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; NEUROPHARMACOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; REFSUM DISEASE; SPASTICITY;

EID: 0032839812     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979205     Document Type: Article

References (11)

1. 1 Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, et al: Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996; 271: 1423-1427
2. 2 Chamberlain S, Shaw J, Rowland A, Wallis J, South S, Nakamura Y, von Gabain A, Farrall M, Williamson R: Mapping of mutation causing Friedreich's ataxia to human chromosome 9. Nature 1988; 334: 248-250
3. 3 Friedreich N: Über degenerative Atrophie der spinalen Hinterstränge. Virchows Arch. 1863; (A) 26: 391-419
4. 4 Klockgether T, Zühlke C, Schulz JB, Bürk K, Fetter M, Dittmann H, Skalej M, Dichgans J: Friedreich's ataxia with retained tendon reflexes: molecular genetics, clinical neurophysiology and magnetic resonance imaging. Neurology 1995; 46: 18-121
5. 5 Pranzatelli M: Serotonin and human myoclonus: rationale for the use of serotonin receptor agonists and antagonists. Arch. Neurol. 1994; 51: 605-617
6. 6 Trouillas P: The cerebellar serotonergic system and its possible involvement in cerebellar ataxia. Can. J. Neurol. Sci. 1993; 20 (Suppl. 3): 78-82
7. 7 Trouillas P, Brudon F, Adeleine P: Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan. Arch. Neurol. 1988; 45: 1217-1222
8. 1A-agonist, is active in cerebellar ataxia: results of a double-blind drug placebo study in patients with cerebellar cortical atrophy. Arch. Neurol. 1997; 54: 49-52
9. 9 Wainberg M, Barbeau H, Gauthier S: The effects of cyproheptadine on locomotion and on spasticity in patients with spinal cord injuries. J. Neurol. Neurosurg. Psychiatry. 1990; 53: 754-763
10. 10 Wallis DI, Wu J, Wang X: Descending inhibition in the neonate rat spinal cord is mediated by 5-hydroxytryptamine. Neuropharmacology 1993; 32: 73-83
11. 11 Wessel K, Schroth G, Diener HC, Müller-Forell W, Dichgans J: Significance of MRI-confirmed atrophy of the cranial spinal cord in Friedreich's ataxia. Eur. Arch. Psychiat. Neurol. Sci. 1989; 238: 225-230